Category Archives: News

First Edible Mascot Delights Fans

The recent Pop-Tarts Bowl in Orlando, Florida, made history by showcasing the first edible mascot in the realm of sports. In a quirky move that captivated the internet, the Kansas State Wildcats triumphed over the NC State Wolfpack with a score of 28-19, culminating in the devouring of a colossal pastry emerging from a larger-than-life toaster.

As part of this creative marketing ploy, the victorious team celebrated by consuming the giant pastry, marking a distinctive trophy presentation that featured two actual Pop-Tarts nestled into slots atop a silver football.

Enthusiastic fans flooded various online platforms, including X (formerly Twitter), expressing their amusement through a plethora of memes.

Heidi Ray, senior director of brand marketing at Pop-Tarts (Kellanova), explained, “Campaigns that earn both coverage and conversation have a disproportionate business impact… We have been blown away by the reaction and engagement, which we are still analyzing. But, at this point, we are looking at success that rivals a major Super Bowl moment.”

Originally named the Blockbuster Bowl, the Pop-Tarts Bowl has a rich history, commencing in Miami back in 1990 and drawing over 74,000 fans. Presently hosted at Orlando’s Camping World Stadium, the event falls under the oversight of Florida Citrus Sports, a nonprofit organization managing regional events.

Various sponsors have graced the game over the years, including a multi-year deal with Florida Citrus Sports. The game underwent a rebranding as the Cheez-It Bowl for the past three seasons, featuring memorable celebrations such as dumping buckets of Cheez-Its on the winning coaches’ heads.

California is Making Food Safer

California is the first U.S. state to ban four potentially harmful food and drink additives that are linked to disease. The California Food Safety Act now prohibits the use of brominated vegetable oil, potassium bromate, propylparaben, and red dye 3, commonly found in candies, fruit juices, and cookies. These substances are already banned in many countries.

Supporters of this law are reassuring consumers that popular products are not going to suddenly vanish from stores; rather, companies who use these ingredients are going to have to change their recipes to include healthier alternatives. The law will take effect in 2027, which will give the manufacturers time to reformulate their products.

There was a false claim that California aimed to ban Skittles. Assemblymember Jesse Gabriel clarified that Skittles with alternative ingredients are already sold in the European Union, where these additives are banned. The law doesn’t ban foods but requires companies to use safer alternatives.

Other countries, including the EU, the UK, Canada, Australia, New Zealand, China, and Japan, have banned these additives. Major brands like Coke, Pepsi, Dunkin’, and Panera have removed them from their products voluntarily.

Egg Prices are Finally Returning to Normal

Between January 2022 and January 2023, the price of eggs increased by 70%, according to data from the Bureau of Labor Statistics. A severe and extended outbreak of the avian flu combined with higher production costs for farmers sent egg prices soaring to an unprecedented $5.30 per dozen in December 2022. Thankfully, the U.S. Department of Agriculture has recently reported that the cost of a dozen eggs has since returned to roughly $1.00.

This dramatic change is a result of the waning of the avian flu and the fact that egg producers have been busy replacing hens. As of May 1, 2023, there were 387 million egg producing hens in the United States, which is a 5% increase over last year. Daniel Sumner, University of California, Davis agricultural economics professor, explained, “There are now more hens and more eggs on the market. That is, supply has increased, and prices have normalized”.  Sumner also predicted that, barring another flu outbreak, egg prices should remain moderate for the foreseeable future.  

Summer Air Travel is on the Rise

Air travel may finally be recovering from the COVID-19 pandemic. Although some experts predicted that rising inflation would keep vacationers close to home, Delta Airlines reports a 17% increase in demand for flights in the quarter that ends in June.

Despite rising fares, according to Expedia, there has been a 25% increase in flight searches for summer trips, and an even larger increase in searches for international travel to Europe and Asia.

Airlines are also feeling hopeful about the return of corporate travel. Now that offices are reopening after the pandemic, business people are once again willing to fly to meetings. This summer, a high percentage of seats are expected to be filled by people traveling for work.

The next challenge for the airlines will be to ensure they are prepared for this increase in travelers. Throughout the past year, the airline industry was plagued with thousands of cancellations due to bad weather and internal issues. To ensure that passengers arrive at their destinations in a timely manner, Daniel Janki, CFO of Delta, said that Delta has devoted time and energy to “ensuring that we have the right resources in the right places with the right level of training.”

California is on Track to Produce Affordable Insulin

Drug company Covica Rx has contracted with the state of California to create affordable insulin. Pending FDA approval, this 10-year, $50 million agreement will allow Civica to start making CalRx insulin in late 2023.  

People with Type 1 diabetes do not produce enough insulin, and they rely on manufactured insulin in order to survive. Currently, insulin can cost up to $300 for a 10 milliliter vial. But insulin produced by Civica for the state of California will cost no more than $30 per 10 milliliter vial, even for the uninsured. This will save patients who pay out of pocket up to $4,000 a year. 

This arrangement is part of California’s CalRx initiative which aims to reduce the cost of medications by producing generic drugs under the state’s own label. 

Civica will be producing three types of insulin, glargine, lisprom and aspart, which will all be the equivalent of the insulin produced by the major drug companies. Although California has initiated this project, the medicines will be available all across the country.

The production of affordable insulin is a game changer for Americans with diabetes. NPR.com reported that 1 out of 6 Americans living with diabetes ration their supply of insulin due to the high cost of the drug. University of California College of Law professor Robin Feldman called this an “extraordinary move in the pharmaceutical industry, not just for insulin but potentially for all kinds of drugs.”

Several pharmaceutical companies such as Eli Lilly and Sanofi have announced that they will also be cutting the cost of insulin in the upcoming year.